Company Profile
Convatec Group plc, trading as Convatec, is a medical products and technologies company based in London, England, offering products and services in the areas of advanced wound care, ostomy care, continence care and infusion care. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Approach to Healthcare
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring.
Impact of Products/Services on Healthcare:
Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
Innovation
Innovation is a key part of our strategy and is helping to drive growth in the fastest growing segments of our markets. We continued to strengthen our Technology & Innovation capabilities; R&D expenditure of $102m . New product innovation accelerated with a broadening pipeline across our chronic care markets, including eight new products launched between 2022-24.
Recent Products launches are:
– Esteem Body – Ostomy
– ConvaFoam – Woundcare
– GentleCath Air for Women and Men – Continence
Future Direction
We have a strong pipeline of innovative products many developed and tested at our Innovation Centre based in Deeside, Wales